Drug discovery and development encompass the identification of new therapeutic compounds, their optimization, and the evaluation of their safety and efficacy. This multi-stage process involves target identification, hit-to-lead optimization, preclinical testing, and phased clinical trials. Advanced computational methods, high-throughput screening, and artificial intelligence are revolutionizing the drug discovery pipeline. The development stage focuses on translating laboratory findings into clinically viable drugs through rigorous testing and regulatory compliance. Current trends emphasize precision medicine, repurposing of existing drugs, and sustainable manufacturing practices. Effective collaboration among academia, industry, and regulatory agencies is key to accelerating innovation.
Subtracts:
Related Conferences:
World Congress on Pharmacology & Toxicology (WCPT) | International Conference on Clinical Pharmacology & Therapeutics (ICCPT) | Global Summit on Drug Discovery and Development (GSDDD) | European Conference on Toxicology & Applied Pharmacology (ECTAP) | International Symposium on Experimental and Clinical Toxicology (ISECT)
Related Associations:
International Union of Basic and Clinical Pharmacology (IUPHAR) | British Pharmacological Society (BPS) | American Society for Pharmacology and Experimental Therapeutics (ASPET) | European Society of Toxicology (EUROTOX) | Society of Toxicology (SOT) | Asia Pacific Association of Pharmacologists (APAP) | Federation of Asian Pharmacological Societies (FAPS) | International Society for the Study of Xenobiotics (ISSX)
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
